Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc.

NASDAQ:GLSI

Overview | Financials
Company Name Greenwich LifeSciences, Inc.
Symbol GLSI
Currency USD
Price 14.93
Market Cap 196,250,371
Dividend Yield 0%
52-week-range 7.58 - 21.44
Industry Biotechnology
Sector Healthcare
CEO Mr. Snehal S. Patel
Website https://greenwichlifesciences.com

An error occurred while fetching data.

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone

Related Stocks

Rezolute, Inc. logo

Rezolute, Inc.

RZLT

5.25 USD

Selecta Biosciences, Inc. logo

Selecta Biosciences, Inc.

SELB

0.881 USD

FONAR Corporation logo

FONAR Corporation

FONR

16.82 USD

CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc.

CTMX

1.23 USD

Financials

Numbers are in millions USD

Numbers are in millions USD